| Nov 20 |
Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
|
| Nov 8 |
Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade
|
| Nov 6 |
Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues
|
| Nov 5 |
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 5 |
Stoke Therapeutics GAAP EPS of -$0.47 beats by $0.06, revenue of $4.89M beats by $1.29M
|
| Nov 5 |
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
|
| Nov 1 |
Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
|
| Oct 29 |
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
| Oct 12 |
Stoke Therapeutics assumed with an Outperform at Leerink
|
| Oct 12 |
Stoke Therapeutics, Inc (STOK): Pioneering RNA Medicine for Genetic Diseases
|
